Lidé

Jméno Hnízda Aleš
Pozice Postdoktorand
Aleš Hnízda

Aleš Hnízda, Ph.D.

Postdoctoral Fellow


Structural Biology
Institute of Organic Chemistry and Biochemistry ASCR, v.v.i.
Flemingovo nám. 2, CZ-166 10 Prague 6, Czech Republic

☎: (+420) 723 156 689

 
Education
2006-2012 Ph.D. in biochemistry and pathobiochemistry, Institute of Inherited Metabolic Disorder, First Faculty of Medicine, Charles University, Prague.
2004-2007 Bc., bachelor parallel study - program: Teaching of chemistry, Institute of Chemical Technology, Prague.
2001-2006 M.Sc. (Ing.) in Biochemistry, Faculty of Food and Biochemical Technology, Institute of Chemical Technology, Prague.
 
Appointments
since 2012 Postdoctoral fellow, Group of Structural Biology, Institute of Organic Chemistry and Biochemistry AS CR, Prague.
since 2006 Researcher, Laboratory of Biochemical Genetics, Institute of Inherited Metabolic Disorder, First Faculty of Medicine, Charles University, Prague.
2005 Laboratory technician, Laboratory of Molecular Pathology, Institute of Inherited Metabolic Disorder, First Medical Faculty, Charles University, Prague.
 
Teaching
2011 Supervisor of the IMFSA project "Conformational studies of cystathionine β-synthase mutants".
2008-2009 Consultant of diploma thesis "Conformational stability of cystathione β-synthase and its mutants".
 
Workshops and courses
2008 49 th Annual Short Course in Medical and Experimental Mammalian Genetics", Jackson Laboratory, Bar Harbour.
2006 Nové Hrady Summer academic courses 2006", project "Utilization of crystallographic techniques in order of solving protein structure and their methodology", Jihočeská Univerzita, Biotechnologické centrum Nové Hrady.
 
Awards
2012 The Best Student of First Medical Faculty, Charles University in Prague - Josef Hlávka Foundation.
2010 2nd Price - The Best Publication of Ph.D. students at the First Faculty of Medicine; Endowment Fund Scientia.
 
Research interest
  • structure and regulation of modular proteins
  • structural impact of disease-causing mutations
  • structure-based drug design